CTABF News and Press, Canntab Therapeutics Ltd From 11/20/19

TORONTO, Ontario , Nov. 20, 2019 /PRNewswire/ -- Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, today announced the signing o...

Canntab Achieves Key Milestone: Canntab Enters Into Supply & Distribution Agreements With Exactus for the Purchase of Hemp-Derived CBD Oil and the Distribution of Canntab's Hard Pill Formulations in the United States Canntab Achieves Key Milestone: Canntab Enters Into Supply &a...

Canntab to utilize the advanced BOSS extraction system from Word Class Extractions to further its own extraction capabilities Canada NewsWire TORONTO, Oct. 8, 2019 TORONTO , Oct. 8, 2019 /CNW/ -   Canntab Therapeutics Limited ( CSE:PILL.CN ) ( OTCQX:CTABF ) ( FRA:TBF...

Vancouver, British Columbia--(Newsfile Corp. - August 16, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, has received an initial assessment from the Geneva-based Internati...

Canntab Receives Initial Indication of Patentability for Immediate Release Cannabidiol Formulation Canada NewsWire TORONTO, Aug. 15, 2019 TORONTO , Aug. 15, 2019 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN ) (OTCQX: CTABF ) (FRA: TBF1.F ) (the " Compa...

Vancouver, British Columbia--(Newsfile Corp. - August 1, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blends, has updated investors about significant developments. Canntab, with headquarters ...

Commercial batch manufacturing of oil-filled gel capsules to begin in Cobourg , leading to a Health Canada request for authorization to begin full scale production and sale. Construction nears completion in Markham , and Canntab intends to request a Health Canada inspection in early fal...

ATLANTA, GA / ACCESSWIRE / June 24, 2019 / CannaInvestor Magazine, the leading industry investment magazine for cannabis investors, analysts, executives, entrepreneurs, and financial media, announced today that it has published its June/July 2019 Issue of the U.S. and Canadian CannaInvestor ...

TORONTO, ON / ACCESSWIRE / June 24, 2019 / Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQX: CTABF) (FRA:TBF1.F) (the " Company " or " Canntab "), the leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blends, is pleased to announce that it is the featured company...

Vancouver, British Columbia--(Newsfile Corp. - May 31, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blends, has signed a term sheet with Heritage Cannabis Holdings. Under the Term Sheet, Ca...